Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

AbbVie revela resultados de estudo que demonstra impacto da Artrite Reumatoide na qualidade de vida e produtividade de pacientes no Brasil e América Latina

-- Outubro é mundialmente dedicado à conscientização sobre os riscos da artrite reumatoide e esta é a primeira vez que um estudo com este tema é conduzido no país

-- Brasil tem o maior índice de desemprego entre pacientes com artrite reumatoide (60 por cento), comparativamente à Argentina, Colômbia e México

-- A artrite reumatoide faz parte do grupo das chamadas "doenças musculoesqueléticas", que já configuram uma entre as três categorias responsáveis pelo maior número de afastamentos do trabalho por mais de 15 dias (*)


News provided by

AbbVie

Oct 07, 2015, 12:05 ET

Share this article

Share toX

Share this article

Share toX

SÃO PAULO, 7 de outubro de 2015 /PRNewswire/ -- Entre os 309 pacientes avaliados em centros de reumatologia de quatro países (Brasil, Argentina, Colômbia e México), os brasileiros com artrite reumatoide são os mais afetados pela doença, no que diz respeito à qualidade de vida e à produtividade no trabalho. Esta é uma das conclusões do estudo PROSE - RA (do inglês Patient Reported Outcomes Survey of Employment in Patients with Rheumatoid Arthritis), inédito no Brasil. Os três centros brasileiros que fizeram parte do estudo são Serviço de Reumatologia do Hospital de Clínicas de Porto Alegre (RS), Serviço de Reumatologia da Universidade Federal de São Paulo (UNIFESP) e Centro  Paulista de Investigações Clínicas (CEPIC), também de São Paulo. O  coordenador de todo o estudo (incluindo países latino-americanos é o brasileiro Ricardo Xavier, do HC de Porto Alegre.  

Outras principais descobertas do PROSE-RA:

  • A artrite reumatoide afeta tanto a qualidade de vida quanto o desempenho profissional dos pacientes nos quatro países. Os brasileiros, entretanto, relataram mais enfaticamente o impacto negativo da doença na maioria dos aspectos avaliados, apesar de tendências semelhantes apresentadas nos quatro países.
  • Os pacientes brasileiros com artrite reumatoide apresentam a menor taxa de empregabilidade (40 por cento), enquanto os argentinos apresentam a maior, com 73 por cento dos pacientes empregados, seguidos pela Colômbia (61 por cento) e México (54 por cento).
  • Sensação de dor e desconforto são sintomas reportados por 83 por cento dos pacientes brasileiros, contra 67 por cento dos argentinos, 70 por cento dos colombianos e 71 por cento dos mexicanos.

O PROSE acompanhou os participantes do estudo por 12 meses e seus resultados baseiam-se na percepção  e no relato dos próprios pacientes sobre o impacto da artrite reumatoide na qualidade de vida e na produtividade no trabalho. Participaram da pesquisa pacientes acima de 18 anos que responderam questionários com informações e percepções sobre produtividade e dificuldade/limitações de atividades no trabalho, além de avaliações sobre o grau de comprometimento com a doença, entre outros aspectos.

Principais causas de afastamento do trabalho no Brasil  - As doenças musculoesqueléticas, da qual a artrite reumatoide faz parte, segundo a classificação do Ministério da Previdência Social, variam de um período para o outro, estabelecendo-se entre a segunda e terceira causa mais frequente de necessidade de auxílio-doença (afastamento do trabalho, por motivo de doença, por mais de 15 dias consecutivos).

Sobre Artrite Reumatoide

A artrite reumatoide é uma doença crônica cuja principal característica é a inflamação das juntas. A inflamação persistente, se não tratada de forma adequada, pode levar ao inchaço e rigidez das juntas, o que ocasiona limitações para execução das atividades rotineiras e para o trabalho.  Acomete cerca de 1,5 por cento da população, sendo mais frequente em mulheres e se desenvolve por volta dos 35 anos de idade. Principais sintomas: dor, inchaço e rigidez nas juntas, cansaço, perda de apetite e de peso, febre, sensação de fraqueza.

Diagnóstico - Não existe um teste único para determinar o diagnóstico de artrite reumatoide. Os especialistas baseiam-se em avaliação e histórico clínico do paciente e exames laboratoriais e de imagem.

Sobre a AbbVie – A AbbVie, companhia biofarmacêutica global baseada em pesquisa, foi formada em 2013, a partir de sua separação da Abbott Laboratories. A missão da companhia é usar seu conhecimento, sua equipe dedicada e estratégia específica em inovação, para desenvolver e comercializar terapias avançadas que atendam as necessidades de algumas das mais complexas e sérias doenças do mundo. Junto com sua subsidiária Pharmacyclics, a AbbVie emprega mais de 28.000 pessoas  em todo o mundo e comercializa seus medicamentos em mais de 170 países.  Para mais informação sobre a companhia, seus colaboradores, portfólio e compromissos, acesse www.abbvie.com. Siga @abbvie no Twitter ou conheça as oportunidades de carreira em nossas páginas no Facebook ou Linkedin. 

No Brasil, a AbbVie iniciou suas operações no início de 2014; atualmente emprega mais de 430 pessoas localmente. Seu foco se concentra nas áreas de imunologia, neonatologia, endocrinologia e nefrologia. Entre suas várias áreas de especialização, a AbbVie desenvolve 18 estudos clínicos no Brasil, incluindo mais de 1.500 pacientes e 100 centros de pesquisa.

(*) http://www.previdencia.gov.br/wp-content/uploads/2014/06/Aux-Doenca-Conc-Prev-e-Acid-X-CID-e-Clientela_2014_separado-ate-ABR-previdenciarios.pdf  Acessado em 18 de setembro de 2014

Imprensa no Brasil:
Camila Zanqueta
Gerente de Comunicação, AbbVie

Maria José Arrojo (SPMJ) 
[email protected] 
55 11 3289-2699

FONTE AbbVie

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

AbbVie to Host Third-Quarter 2025 Earnings Conference Call

AbbVie to Host Third-Quarter 2025 Earnings Conference Call

AbbVie (NYSE: ABBV) will announce its third-quarter 2025 financial results on Friday, October 31, 2025, before the market opens. AbbVie will host a...

Natrelle® Awarded Supplier Agreement from Vizient

Natrelle® Awarded Supplier Agreement from Vizient

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced today that Natrelle® has been named a supplier by Vizient, Inc., the nation's largest...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Human Resource & Workforce Management

Human Resource & Workforce Management

Medical Pharmaceuticals

Medical Pharmaceuticals

Pharmaceuticals

Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.